ScripAstraZeneca’s Investor Appreciation On the announcement of its second-quarter results, AstraZeneca’ stock price rose by 2% and closed in London and in New York up by about 3%. In contrast, the NYSE A
Pink SheetUS President Donald Trump appears to be giving the drug industry more time to voluntarily come up with ways to bring American drug prices more in line with those paid by other wealthy nations, a sign
ScripUS President Donald Trump appears to be giving the drug industry more time to voluntarily come up with ways to bring American drug prices more in line with those paid by other wealthy nations, a sign
ScripGSK remains confident its multiple myeloma therapy Blenrep can gain US approval and hit blockbuster revenue forecasts but analysts are skeptical. The BCMA-targeted antibody-drug conjugate was at the f